Oruka Therapeutics, Inc.

This study is testing an experimental drug called ORKA-001 for people with moderate-to-severe plaque psoriasis. Researchers want to see if the drug can completely clear skin symptoms and maintain that improvement over a year. The study involves 80 adults who will receive either t…

This is the first study to give the experimental drug ORKA-002 to people. Its main purpose is to check if it is safe and to see how the body processes it. The study will involve about 24 healthy volunteers who will receive a single injection. Researchers will carefully monitor pa…